LUNDEMOSE ANKER MD, PH.D, DSC 4
4 · OSI PHARMACEUTICALS INC · Filed Jun 9, 2010
Insider Transaction Report
Form 4
LUNDEMOSE ANKER MD, PH.D, DSC
Exec. VP & Pres. OSI Prosidion
Transactions
- Disposition from Tender
Common Stock
2010-06-07$57.50/sh−1,675$96,313→ 0 total